All

API

FDF

Price

Services

Excipients

Enquiries

Find

Active Pharmaceutical Ingredients
Finished Drug Formulations
Price
Excipients
Services
Marketplace

Market Place

Post Enquiry

Grow Your Pharma Business Digitally

Scorr-Insert

X

Find Clinical Drug Development Pipelines & Deals | PipelineProspector

A collaboration with SCORR Marketing

All Data

Filters

refresh

×

FILTER DATA :

News Type

Company

Product Type

Deal Size

Upfront Payment

refresh

Product Type

Companies

Nuritas

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

IRELAND Ireland

Post An Enquiry

ASCO 2020

Participation Not Confirmed

Update your events

Nuritas Leverages AI Platform to Identify Therapeutic Peptides for the Treatment of COVID-19

Contact the Supplier

Lead Product(s): Peptides

Therapeutic Area: Infections and Infectious Diseases

Highest Development Status: Undisclosed Product Type: Large molecule

Partner/Sponsor/Collaborator: Advanced Computing in Europe

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Funding April 22, 2020

Details:

Under the terms of the grant, Nuritas will use its AI platform to classify antiviral peptides as well as cytokine-regulating peptides to build a peptide cocktail for therapy.